Intervention Review

You have free access to this content

Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease

  1. Esther J van Zuuren1,*,
  2. Zbys Fedorowicz2

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 12 JUN 2013

Assessed as up-to-date: 5 JUN 2013

DOI: 10.1002/14651858.CD010155.pub2


How to Cite

van Zuuren EJ, Fedorowicz Z. Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease. Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD010155. DOI: 10.1002/14651858.CD010155.pub2.

Author Information

  1. 1

    Leiden University Medical Center, Department of Dermatology, Leiden, Netherlands

  2. 2

    The Cochrane Collaboration, UKCC (Bahrain Branch), Awali, Bahrain

*Esther J van Zuuren, Department of Dermatology, Leiden University Medical Center, PO Box 9600, B1-Q, Leiden, 2300 RC, Netherlands. E.J.van_Zuuren@lumc.nl.

Publication History

  1. Publication Status: New
  2. Published Online: 12 JUN 2013

SEARCH

  1. You have free access to this content

    Current Version

    Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease

    Esther J van Zuuren and Zbys Fedorowicz

    Article first published online: 12 JUN 2013 | DOI: 10.1002/14651858.CD010155.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease

    Zbys Fedorowicz, Esther J van Zuuren and Amani Al Hajeri

    Article first published online: 17 OCT 2012 | DOI: 10.1002/14651858.CD010155